// App-Quantinova.ai

4518 : Absolute Lymphocyte Count At Day+15 and +30 Post-ASCT As Predictors of Early and 1-Year Mortality for Patients with AL Amyloidosis Treated with a Single Autologous Stem Cell Transplant

Researchers

Presenter

  • Donna Reece

Principal Investigators

  • Suzanne Trudel

  • Christine I. Chen

  • Norman Franke

  • Andrew Winter Sr

  • Rodger E. Tiedemann

  • Vishal Kukreti

Medical Centers

  • McLaughlin Centre for Molecular Medicine, Princess Margaret Hospital, Toronto, ON, Canada

  • Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

  • AL Amyloidosis

  • Solid malignancies

  • Amyloid disease

Biomarkers

  • Natural Killer cells

  • C reactive protein

  • Creatinine

  • Human albumin

  • Lactate dehydrogenase

  • Lymphocyte count

Drug/Treatment

  • Melphalan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved